Sarah K. Dutcher, PhD, MS

Epidemiologist
Office of Surveillance and Epidemiology, Center for Drug Evaluation and Research, U.S. Food and Drug Administration

Presentation(s):

• L-1B - Comparing Outcomes in Trial-eligible vs Real-world COVID-19 Patients: The Case of Invasive Mechanical Ventilation

  Monday, August 23, 2021
  5:30 PM – 6:30 PM US Eastern Time

• L-1C - Outpatient-identified COVID-19 and Subsequent Hospitalized Thrombotic Events

  Monday, August 23, 2021
  5:30 PM – 6:30 PM US Eastern Time